Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells von SPANER, D. E, SHI, Y, RADVANYI, L, WHITE, D, MENA, J, HAMMOND, C, TOMIC, J, HE, L, TOMAI, M. A, MILLER, R. L, BOOTH, J

Volltext

Epidemiology of sepsis in Internal Medicine Units of Apulia: results of SEMINA (SEpsis Management in INternal medicine Apulia) study von Belfiore, A, Mastroianni, F, Ventrella, F, Errico, M, Suppressa, P, Tomai, M, Sabatino, S, De Palma, G, Pappagallo, F, Erbi, A, Simone, O, Longo, S, Vendemiale, G, Balsamo, M, Tartaglia, I, Guida, P

Volltext

A Randomized, Controlled, Molecular Study of Condylomata Acuminata Clearance during Treatment with Imiquimod von Tyring, Stephen K., Arany, Istvan, Stanley, Margaret A., Tomai, Mark A., Miller, Richard L., Smith, Michael H., McDermott, Daniel J., Slade, Herbert B.

Volltext

Imiquimod, a Topical Immune Response Modifier, Induces Migration of Langerhans Cells von SUZUKI, H, BINGHE WANG, SHIVJI, G. M, TOTO, P, AMERIO, P, TOMAI, M. A, MILLER, R. L, SAUDER, D. N

Volltext

A Comparative Study of Dual-X-ray Absorptiometry and Quantitative Ultrasonography for the Evaluating Bone Status in Subjects with Rett Syndrome von Caffarelli, C., Hayek, J., Pitinca, M. D. Tomai, Nuti, R., Gonnelli, S.

Volltext

Cytokine Induction in Hairless Mouse and Rat Skin After Topical Application of the Immune Response Modifiers Imiquimod and S-28463 von Imbertson, Linda M., Couture, Aimee M., Gibson, Sheila J., Smith, Rose M.A., Miller, Richard L., Reiter, Michael J., Wagner, Tamara L., Tomai, Mark A., Beaurline, Joseph M.

Volltext

Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod von Gibson, Sheila J, Lindh, Jana M, Riter, Tony R, Gleason, Raymond M, Rogers, Lisa M, Fuller, Ashley E, Oesterich, JoAnn L, Gorden, Keith B, Qiu, Xiaohong, McKane, Scott W, Noelle, Randy J, Miller, Richard L, Kedl, Ross M, Fitzgerald-Bocarsly, Patricia, Tomai, Mark A, Vasilakos, John P

Volltext

Is Alexithymia Related to Colon Cancer? A Survey of Patients Undergoing a Screening Colonoscopy Examination von Lauriola, M., Panno, A., Tomai, M., Ricciardi, V., Potenza, A. E.

Volltext

Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5 von Arany, Istvan, Tyring, Stephen K, Stanley, Margaret A, Tomai, Mark A, Miller, Richard L, Smith, Michael H, McDermott, Daniel J, Slade, Herbert B

Volltext

Molecular Mechanisms of B Lymphocyte Activation by the Immune Response Modifier R-848 von Bishop, Gail A, Hsing, Yina, Hostager, Bruce S, Jalukar, Sangita V, Ramirez, Luis M, Tomai, Mark A

Volltext

Immunomodulation as a treatment strategy for genital herpes: review of the evidence von Miller, R.L, Tomai, M.A, Harrison, C.J, Bernstein, D.I

Volltext

Correlation between Pretreatment Levels of Interferon Response Genes and Clinical Responses to an Immune Response Modifier (Imiquimod) in Genital Warts von ARANY, I, TYRING, S. K, BRYSK, M. M, STANLEY, M. A, TOMAI, M. A, MILLER, R. L, SMITH, M. H, MCDERMOTT, D. J, SLADE, H. B

Volltext

Imiquimod applied topically : a novel immune response modifier and new class of drug von MILLER, R. L, GERSTER, J. F, OWENS, M. L, SLADE, H. B, TOMAI, M. A

Volltext

Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODN von Vasilakos, John P., Smith, Rose M.A., Gibson, Sheila J., Lindh, Jana M., Pederson, Linda K., Reiter, Michael J., Smith, Michael H., Tomai, Mark A.

Volltext

Daily or Weekly Therapy with Resiquimod (R-848) Reduces Genital Recurrences in Herpes Simplex Virus–Infected Guinea Pigs during and after Treatment von Bernstein, David I., Harrison, Christopher J., Tomai, Mark A., Miller, Richard L

Volltext

Modulation of TH1 and TH2 Cytokine Production with the Immune Response Modifiers, R-848 and Imiquimod von Wagner, Tamara L., Ahonen, Cory L., Couture, Aimee M., Gibson, Sheila J., Miller, Richard L., Smith, Rose M., Reiter, Michael J., Vasilakos, John P., Tomai, Mark A.

Volltext

Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways von Megyeri, Klara, Au, Wei-Chun, Rosztoczy, Istvan, Raj, N. Babu K., Miller, Richard L., Tomai, Mark A., Pitha, Paula M.

Volltext

Imiquimod 5% cream (Aldara™) von HB, Slade, ML, Owens, MA, Tomai, RL, Miller

Volltext

The Immune Response Modifiers Imiquimod and R-848 Are Potent Activators of B Lymphocytes von Tomai, Mark A., Imbertson, Linda M., Stanczak, Tamara L., Tygrett, Lorraine T., Waldschmidt, Thomas J.

Volltext

Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8 von Gorden, Keith B, Gorski, Kevin S, Gibson, Sheila J, Kedl, Ross M, Kieper, William C, Qiu, Xiaohong, Tomai, Mark A, Alkan, Sefik S, Vasilakos, John P

Volltext